Atlas Trials

First in Man Study Investigating the Biodistribution, the Safety and Optimal Recommended Dose of a New Radiolabelled Monoclonal Antibody Targeting Frizzled Homolog 10

Clinical trial NCT01469975 · TERMINATED

Trial details

NCT number
NCT01469975
Sponsor
Centre Leon Berard
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Sarcoma, Synovial
Start date
2011-12-01
Primary completion
2015-02-03
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.